ATE53492T1 - Formulierung von entzuendungshemmenden arzneimitteln. - Google Patents

Formulierung von entzuendungshemmenden arzneimitteln.

Info

Publication number
ATE53492T1
ATE53492T1 AT85307055T AT85307055T ATE53492T1 AT E53492 T1 ATE53492 T1 AT E53492T1 AT 85307055 T AT85307055 T AT 85307055T AT 85307055 T AT85307055 T AT 85307055T AT E53492 T1 ATE53492 T1 AT E53492T1
Authority
AT
Austria
Prior art keywords
guanidino
imidazolyl
thiazole
methyl
formulation
Prior art date
Application number
AT85307055T
Other languages
English (en)
Inventor
John Lawrence Lamattina
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE53492T1 publication Critical patent/ATE53492T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electron Beam Exposure (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
AT85307055T 1984-10-11 1985-10-02 Formulierung von entzuendungshemmenden arzneimitteln. ATE53492T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65975284A 1984-10-11 1984-10-11
US06/765,415 US4636498A (en) 1984-10-11 1985-08-15 Formulation of antiinflammatory drugs

Publications (1)

Publication Number Publication Date
ATE53492T1 true ATE53492T1 (de) 1990-06-15

Family

ID=27097890

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85307055T ATE53492T1 (de) 1984-10-11 1985-10-02 Formulierung von entzuendungshemmenden arzneimitteln.

Country Status (16)

Country Link
US (1) US4636498A (de)
EP (1) EP0178121B1 (de)
CN (1) CN1011196B (de)
AT (1) ATE53492T1 (de)
AU (1) AU558668B2 (de)
CA (1) CA1251138A (de)
DE (1) DE3578125D1 (de)
DK (1) DK165964C (de)
EG (1) EG17529A (de)
FI (1) FI853948L (de)
GR (1) GR852459B (de)
IE (1) IE58740B1 (de)
IL (1) IL76647A0 (de)
NZ (1) NZ213756A (de)
PH (1) PH21400A (de)
PT (1) PT81280B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
NL8902338A (nl) * 1988-09-20 1990-04-17 Glaxo Group Ltd Farmaceutische preparaten.
WO1994028898A1 (en) * 1993-06-15 1994-12-22 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine
US20060281775A1 (en) 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715112A (de) * 1966-11-21 1968-05-22
US4230717A (en) * 1978-12-29 1980-10-28 Lovelace Alan M Administrator Indomethacin-antihistamine combination for gastric ulceration control
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
BE894286A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)

Also Published As

Publication number Publication date
IE852494L (en) 1987-02-15
DK165964B (da) 1993-02-22
IE58740B1 (en) 1993-11-03
EP0178121A2 (de) 1986-04-16
DK165964C (da) 1993-07-26
EG17529A (en) 1993-08-30
EP0178121B1 (de) 1990-06-13
PH21400A (en) 1987-10-15
CN1011196B (zh) 1991-01-16
AU4848585A (en) 1986-05-08
GR852459B (de) 1986-02-11
CN85107521A (zh) 1986-08-06
FI853948A7 (fi) 1986-04-12
AU558668B2 (en) 1987-02-05
PT81280A (en) 1985-11-01
US4636498A (en) 1987-01-13
FI853948A0 (fi) 1985-10-10
FI853948L (fi) 1986-04-12
IL76647A0 (en) 1986-02-28
DE3578125D1 (de) 1990-07-19
DK463885A (da) 1986-04-12
EP0178121A3 (en) 1988-10-05
NZ213756A (en) 1988-11-29
PT81280B (pt) 1988-02-17
DK463885D0 (da) 1985-10-10
CA1251138A (en) 1989-03-14

Similar Documents

Publication Publication Date Title
DE3866938D1 (de) Steroid-5-alpha-reduktase-inhibitoren.
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
IT8919316A0 (it) Benzoderivati di composti eterociclici contenenti azoto.
BR1100546A (pt) Compostos e composições de piridil imidazol.
MY106964A (en) Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
IT8567393A0 (it) Derivati di delta 2-1,2,4-triazolin5-one e composizioni erbicide cheli contengono
DK148232C (da) 2-methoxyethylesteren af 4-hydroxy-2-methyl-2h-1,2-benzothiazin-3-carboxylsyre-1,1-dioxid og fremgangsmaade til omdannelse af denne til 4-hydroxy-2-methyl-n-2-pyridyl-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid (piroxicam)
ATE53492T1 (de) Formulierung von entzuendungshemmenden arzneimitteln.
FI852743A7 (fi) Asetyleenisiä fenoksipropanolijohdannaisia ja farmaseuttisia koostumuksia hypertoniahoitamiseksi.
NO954892D0 (no) Heterosyklisk kjemi
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
IT8421342A0 (it) Composizioni e composti per il trattamento dell'adenoma prostatico.
IT8420007A0 (it) Composizioni poliolefiniche stabilizzate e composti stabilizzanti adatti allo scopo.
FI893909A0 (fi) Menetelmä polymeerikuonan muodostumisen estämiseksi
DK527685D0 (da) 5-(omega-phenethylamino-alkyl)-4,5,6,7-tetrahydro-thieno-(3,2-c)-pyridinderivater, fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser
EP0681580A1 (de) Prodrug von entz ndungshemmende 3-acyl-2-oxindol-1-carboxamide.
FI972310A0 (fi) Substituoituja 2-(fosfinyylioksimetyyli-1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja, niitä sisältäviä koostumuksia ja menetelmä niiden käyttämiseksi
FI971831A0 (fi) Heterosyklillä substituoituja propeenihappojohdannaisia NMDA-antagonisteina
IT8920994A0 (it) Nuovi derivati imidazolici ad azione inibente l'enzima trombossanosintetasi.
FI862001A0 (fi) Krok foer fiskande i vatten med undervattensvegetation.
ATE35258T1 (de) 2,6-dimethyl-3-(alkoxycarbonyl oder alkoxyalkoxycarbonyl)-4-(substituiertes phenyl)1,4-dihydropyridin-5-carbons|ureester.
ATE19084T1 (de) 6-aminoalkylpenicillansaeure 1,1-dioxide und derivate als beta-lactamase-inhibitoren.
SU1299112A1 (ru) 3-Метил-5-[(5-нитрофурфурил-2)-тио]-1,2,4-триазол или его гидрохлорид, обладающие антимикробной, анальгетической и противовоспалительной активностью
IT8460938V0 (it) Gruppo estensibile perl'azionamento particolarmente di cancelli e simili.